The AST/ALT ratio is calculated by dividing your serum AST level by your serum ALT level, and the resulting number helps clinicians distinguish between different types of liver disease and even predict outcomes in conditions that have nothing to do with the liver. Often called the De Ritis ratio after the Italian researcher who first described it, this simple division has turned out to be surprisingly versatile, informing diagnoses that range from fatty liver disease and alcoholic hepatitis to Wilson disease and post-heart-attack prognosis.
The Calculation Itself
If your blood work comes back with an AST of 45 U/L and an ALT of 30 U/L, the ratio is 45 ÷ 30 = 1.5. That is the entire formula. No weighting, no age adjustment, no additional lab values needed. In healthy people, the ratio usually hovers around 1.0, give or take. What matters clinically is the direction the ratio shifts and how far it moves from that baseline.
Because the calculation is so straightforward, the real skill lies in interpretation. A ratio below 1, where ALT is the higher enzyme, points toward one set of conditions. A ratio above 1, where AST dominates, points toward a different set. And ratios that climb well above 2 can signal either severe liver damage or something happening entirely outside the liver. The sections below walk through each scenario.
Why AST and ALT Behave Differently
The ratio works as a diagnostic clue because the two enzymes are not distributed the same way in the body. ALT is found mainly in the liver, sitting in the liquid interior of liver cells. AST, by contrast, is present in the liver, heart, skeletal muscle, kidneys, brain, and red blood cells. Within liver cells specifically, about 80% of AST is tucked inside the mitochondria and only about 20% floats in the cytosol, whereas ALT is a cytosol-only enzyme.1ScienceDirect. Aminotransferase
This distribution matters because mild liver injury that damages only the outer cell membrane tends to release the cytosolic enzymes first, sending ALT levels soaring while AST rises more modestly. The ratio drops below 1. More severe injury, the kind that tears apart mitochondria, releases that large mitochondrial AST reserve as well, pushing the ratio higher. And because AST also lives in heart and muscle tissue, anything that damages those organs can raise AST independently of what the liver is doing, further shifting the ratio upward.
When the Ratio Falls Below 1
A ratio under 1 means ALT is higher than AST. The two most common explanations are acute viral hepatitis and non-alcoholic fatty liver disease (NAFLD).
In acute viral hepatitis, both enzymes spike dramatically, but ALT tends to outpace AST. One study of patients with acute viral hepatitis found a mean AST/ALT ratio of about 0.66, compared with roughly 0.94 in healthy controls.2Europasian Journal of Medical Sciences. Evaluation of Liver Enzymes and calculation of AST to ALT ratio in patients with acute viral hepatitis That ALT-dominant pattern reflects the fact that hepatitis viruses primarily damage the cytoplasm of liver cells, where ALT is concentrated, without initially destroying the mitochondria.
In NAFLD and its more inflammatory cousin NASH, a similar pattern emerges. Typical findings in NAFLD include raised ALT and AST with a preserved ALT-to-AST ratio of around 1.5, meaning ALT is about one and a half times higher than AST.3Australian Family Physician. Fatty liver disease A practical guide for GPs A ratio below 1 in someone with risk factors for fatty liver often points toward relatively early-stage disease where inflammation is present but the liver architecture has not yet been significantly disrupted.
An important caveat: a low ratio does not automatically mean mild disease. In acute viral hepatitis, the ratio can sometimes flip above 1, and when it does, that reversal may signal fulminant liver failure rather than a benign course.4PubMed Central. The de ritis ratio: the test of time Context always matters more than the number alone.
When the Ratio Climbs Above 1
A ratio above 1 shifts suspicion toward conditions that damage cells more deeply or that involve organs beyond the liver. The classic association is alcoholic liver disease. In patients with alcohol-related cirrhosis, roughly 69% had a ratio of 2 or higher, and only 8% had a ratio at or below 1. By contrast, patients who were heavy drinkers without cirrhosis typically had ratios at or below 1.5Oxford Academic. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking This finding is worth pausing on: a high ratio in someone who drinks does not simply confirm heavy alcohol use. It suggests the liver has already progressed toward cirrhosis. Heavy drinking alone often keeps the ratio near or below 1.
The reason alcohol-related cirrhosis pushes the ratio so high involves both enzymes. Chronic alcohol exposure damages mitochondria, releasing AST stored there, while simultaneously impairing the liver’s ability to produce new ALT. As the liver scars, it has fewer functioning hepatocytes to release ALT into the blood, and the clearance of AST from circulation slows. Both effects push AST up relative to ALT.
The same pattern appears across other chronic liver diseases as they progress toward fibrosis and cirrhosis. In chronic viral hepatitis and non-alcoholic fatty liver disease, a rising AST/ALT ratio over time predicts long-term complications including fibrosis and eventual cirrhosis.4PubMed Central. The de ritis ratio: the test of time A patient whose ratio was once comfortably below 1 and is now creeping above it deserves closer investigation, even if the absolute enzyme levels have not changed much.
Extreme Ratios and Special Scenarios
Some conditions push the ratio into territory that would be unusual for garden-variety liver disease. Wilson disease, a rare genetic condition that causes copper to accumulate in the liver, is the most dramatic example. When Wilson disease causes acute liver failure, the median AST/ALT ratio in one study was 7.5, with individual values ranging from about 2 to over 18. In patients with acute liver failure from other causes, the median was just 1.0. Using a cutoff of 2.2, the ratio identified Wilson disease with 94% sensitivity and 86% specificity.6PubMed Central. Screening for Wilson Disease in Acute Liver Failure: A Comparison of Currently Available Diagnostic Tests In an emergency department setting where rapid diagnosis of Wilson disease matters enormously, the AST/ALT ratio serves as a fast and freely available screening tool.
On the other end of the spectrum, the ratio can also help track recovery. After severe paracetamol (acetaminophen) poisoning, both AST and ALT spike, but AST falls more rapidly during recovery because its half-life in circulation is shorter. Researchers found that when the ratio dropped to 0.4 or below, it was 99% sensitive for identifying patients whose liver was healing.7PubMed. Can AST/ALT ratio indicate recovery after acute paracetamol poisoning? Clinicians monitoring someone after an overdose can use this falling ratio as reassurance that the liver is on the mend, even while absolute enzyme numbers remain elevated.
Non-Liver Sources That Shift the Ratio
Because AST lives in muscle and heart tissue as well as the liver, anything that damages those tissues will raise AST without touching ALT, artificially inflating the ratio. This is one of the most common reasons the AST/ALT ratio misleads people who try to interpret it without considering the full picture.
Intense exercise is the most frequently overlooked culprit. A study of healthy men found that heavy weightlifting caused AST and ALT to remain elevated for at least seven days afterward, alongside dramatic increases in creatine kinase and myoglobin, both of which are muscle-damage markers.8PubMed Central. Muscular exercise can cause highly pathological liver function tests in healthy men The timing of the rise matters too: AST tends to spike first after muscle damage, pushing the ratio above 1 in the first week, while ALT catches up later and can surpass AST by 10 to 12 days.9Journal of Clinical and Translational Hepatology. Body Building and Aminotransferase Elevations: A Review Someone who hits the gym hard on Monday and gets blood drawn on Wednesday could show an AST/ALT ratio suggestive of liver disease when their liver is perfectly fine.
Red blood cell destruction, or hemolysis, is another non-liver source. AST is present inside red blood cells, so conditions that cause red cells to break apart in the bloodstream release AST into the plasma. In sickle cell disease, for example, AST elevations were far greater than ALT elevations, consistent with AST being released through intravascular hemolysis rather than liver injury.10Clinical medicine. Blood disorders. Pattern of AST and ALT changes in Relation to Hemolysis in sickle cell Disease A clinician seeing a high ratio in a patient with a hemolytic condition needs to account for this before attributing the ratio to liver disease.
Lab Artifacts and Hidden Confounders
Even the blood draw itself can skew the ratio. If the sample is mishandled and red blood cells rupture in the tube, the released AST will falsely elevate the measured level. Research on hemolysis interference found that AST was affected at hemoglobin concentrations so low they were nearly invisible to the eye, while ALT remained stable even in severely hemolyzed samples.11PubMed. Effects of hemolysis interferences on routine biochemistry parameters In practical terms, a slightly pinkish blood sample could yield a ratio that looks worryingly high even though the patient’s actual in-vivo enzyme levels are normal. If your ratio seems inconsistent with the clinical picture, a repeat draw with careful sample handling is warranted.
Vitamin B6 (pyridoxal phosphate) is another under-recognized confounder. Both AST and ALT require B6 as a cofactor to function, and the measured activity of these enzymes in the blood depends partly on B6 status. In hemodialysis patients, who are frequently B6-deficient, both AST and ALT were markedly low, and supplementing B6 brought levels back up to normal.12PubMed. The pathogenesis of decreased aspartate aminotransferase and alanine aminotransferase activity in the plasma of hemodialysis patients: the role of vitamin B6 deficiency Anyone with chronic kidney disease, severe malnutrition, or other conditions that deplete B6 could have misleadingly low aminotransferase readings, which in turn could mask liver disease or distort the ratio.
The Ratio Inside Composite Fibrosis Scores
Clinicians rarely rely on the AST/ALT ratio in isolation. It is built into or used alongside several composite scoring systems designed to estimate liver fibrosis without a biopsy. The APRI score (AST to Platelet Ratio Index) uses AST and platelet count. The FIB-4 index incorporates age, AST, ALT, and platelet count. The BARD score combines body mass index, the AST/ALT ratio, and the presence of diabetes.
In patients with non-alcoholic fatty liver disease, studies comparing these non-invasive scores against transient elastography (a type of liver stiffness measurement) have found positive correlations between Fibroscan results and the AST/ALT ratio, APRI scores, and FIB-4 scores.13PubMed Central. Fibroscan Compared to FIB-4, APRI, and AST/ALT Ratio for Assessment of Liver Fibrosis in Saudi Patients With Nonalcoholic Fatty Liver Disease Research continues to refine which combination of scores works best for ruling in or ruling out advanced fibrosis in overweight and obese patients.14International Journal of Health Sciences and Research. Correlation of Lipid Profile, LFT, AST/ALT Ratio, BARD, FIB-4, NFS Score, TyG Index with Transient Elastography to Detect Better Noninvasive Marker in Overweight and Obese Patient in Tertiary Care Center, West Bengal: A Cross-Sectional Observational Study
The practical takeaway is that the AST/ALT ratio on its own is a blunt instrument. It points in a direction, but the composite scores that fold in platelet count, age, or metabolic factors sharpen the picture considerably. If you see an AST/ALT ratio that concerns you, asking your doctor about FIB-4 or APRI is a reasonable next step, since those scores can be calculated from the same routine blood panel.
Cardiovascular Risk Beyond the Liver
One of the more surprising applications of the De Ritis ratio has nothing to do with the liver at all. Because AST is abundant in heart muscle, the ratio has emerged as a prognostic marker in cardiovascular disease. A study following over 1,300 patients for a median of nearly nine years after acute heart attack found that the De Ritis ratio was an independent predictor of long-term cardiovascular death even after adjusting for other risk factors, with roughly a 23% increase in cardiovascular mortality risk per standard-deviation increase in the ratio.15PubMed Central. De-Ritis Ratio Improves Long-Term Risk Prediction after Acute Myocardial Infarction AST alone lost its predictive power once confounders were accounted for, but the ratio held up, suggesting that the relationship between the two enzymes captures something that individual levels miss.
Similar findings have appeared in patients with stable coronary artery disease. An elevated AST/ALT ratio was associated with nearly three times the risk of death from all causes after adjusting for other factors.16PubMed Central. Elevated AST/ALT ratio is associated with all-cause mortality in patients with stable coronary artery disease: a secondary analysis based on a retrospective cohort study And in patients undergoing coronary stent procedures, those in the highest third of De Ritis ratios had roughly triple the death rate compared with those in the lowest third.17PubMed. De Ritis ratio and long-term major cardiovascular adverse events in patients undergoing elective percutaneous coronary intervention
These cardiovascular findings are still being refined, and the ratio is not yet a standard part of cardiac risk assessment. But they reinforce the broader point that the AST/ALT ratio reflects more than liver health. A high ratio in someone with known heart disease may carry implications worth discussing with a cardiologist, not just a hepatologist.
How Age and Sex Affect Baseline Values
Interpreting the ratio in children and adolescents requires extra caution. In a large study of Korean children and young adolescents, AST levels tended to decrease with age while ALT levels followed a U-shaped curve, which meant the AST/ALT ratio itself gradually increased after around age 13.18Scientific Reports. Updated reference ranges for aminotransferase levels of Korean children and young adolescents based on the risk factors for metabolic syndrome Both enzymes also varied by sex. Applying adult reference ranges to a 10-year-old, or even to a 16-year-old boy versus a 16-year-old girl, can lead to misclassification. Pediatric labs often report age- and sex-specific reference intervals for exactly this reason.
In adults, hormonal status, body composition, and muscle mass all influence baseline enzyme levels. Men tend to have higher ALT than women, partly due to greater liver mass and partly because of differences in fat distribution. Postmenopausal women may see ALT levels change as estrogen declines. None of these shifts invalidate the ratio, but they do mean that what looks like a mildly abnormal result in one demographic group might be completely normal in another. If your ratio is borderline, ask whether the reference range your lab used accounts for your age and sex.
When to Recheck Rather Than React
A single AST/ALT ratio drawn at one moment in time is a snapshot, not a diagnosis. Given all the confounders we have covered, from a hard workout three days earlier to slight hemolysis in the blood tube to B6 status, a mildly abnormal ratio deserves a recheck before it triggers further workup. Most clinicians will ask you to fast overnight, avoid strenuous exercise for at least 48 hours (and ideally a full week if you do heavy resistance training), and make sure the blood draw is clean and non-traumatic. If the ratio normalizes on repeat testing, the original result was probably artifact. If it persists, additional tests such as GGT, alkaline phosphatase, a complete blood count, or imaging can narrow the differential.
Trending the ratio over time is often more valuable than fixating on a single value. A ratio that was 0.7 a year ago and is now 1.3 tells a different story than a ratio that has been sitting at 1.3 for five years. The direction and speed of change can alert clinicians to worsening fibrosis, improving viral clearance, or emerging muscle or cardiac pathology. If you have a liver condition and are getting serial blood work, keeping track of the ratio alongside absolute enzyme levels gives both you and your doctor a richer picture of where things are headed.